CH660488A5 - (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions - Google Patents

(Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions Download PDF

Info

Publication number
CH660488A5
CH660488A5 CH737282A CH737282A CH660488A5 CH 660488 A5 CH660488 A5 CH 660488A5 CH 737282 A CH737282 A CH 737282A CH 737282 A CH737282 A CH 737282A CH 660488 A5 CH660488 A5 CH 660488A5
Authority
CH
Switzerland
Prior art keywords
acid
oligomeric
weight
acid units
oligomeric hydroxycarboxylic
Prior art date
Application number
CH737282A
Other languages
German (de)
English (en)
Inventor
Joachim Dr Franz
Walter Dr Prikoszovich
Zdenek Dr Brich
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH737282A priority Critical patent/CH660488A5/de
Priority to FR8319976A priority patent/FR2537980B1/fr
Priority to BE1/10918A priority patent/BE898430A/fr
Priority to GB08333289A priority patent/GB2135320B/en
Priority to DE19833345314 priority patent/DE3345314A1/de
Priority to IT49520/83A priority patent/IT1197759B/it
Priority to US06/562,470 priority patent/US4801739A/en
Priority to JP58238721A priority patent/JPS59130252A/ja
Priority to GB08527419A priority patent/GB2165849A/en
Priority to GB08527420A priority patent/GB2166652B/en
Priority to GB08527421A priority patent/GB2165454B/en
Publication of CH660488A5 publication Critical patent/CH660488A5/de
Priority to SG15090A priority patent/SG15090G/en
Priority to HK272/90A priority patent/HK27290A/xx
Priority to HK27190A priority patent/HK27190A/xx
Priority to CY1530A priority patent/CY1530A/xx
Priority to CY1529A priority patent/CY1529A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH737282A 1982-12-17 1982-12-17 (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions CH660488A5 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
CH737282A CH660488A5 (en) 1982-12-17 1982-12-17 (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
FR8319976A FR2537980B1 (fr) 1982-12-17 1983-12-12 Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
BE1/10918A BE898430A (fr) 1982-12-17 1983-12-12 Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation.
GB08333289A GB2135320B (en) 1982-12-17 1983-12-14 Oligomeric hydroxycarboxylic acids their production and use
DE19833345314 DE3345314A1 (de) 1982-12-17 1983-12-15 Oligomere hydroxycarbonsaeurederivate, deren herstellung und verwendung
JP58238721A JPS59130252A (ja) 1982-12-17 1983-12-16 ヒドロキシカルボン酸オリゴマ−類
US06/562,470 US4801739A (en) 1982-12-17 1983-12-16 Oligomeric hydroxycarboxylic acid derivatives, their production and use
IT49520/83A IT1197759B (it) 1982-12-17 1983-12-16 Derivati acidi idrossicarbossilici oligomeri,loro preparazione e loro impiego
GB08527419A GB2165849A (en) 1982-12-17 1985-11-07 Co-oligo-lactide-glycolides
GB08527420A GB2166652B (en) 1982-12-17 1985-11-07 Pharmaceutical depot forms containing salmon calcitonin
GB08527421A GB2165454B (en) 1982-12-17 1985-11-07 Pharmaceutical depot forms containing bromocriptine
SG15090A SG15090G (en) 1982-12-17 1990-03-03 Pharmaceutical depot form,containing salmon calcitonin
HK272/90A HK27290A (en) 1982-12-17 1990-04-12 Pharmaceutical depot form containing bromocriptine
HK27190A HK27190A (en) 1982-12-17 1990-04-12 Pharmaceutical depot form containing salmon calcitonin
CY1530A CY1530A (en) 1982-12-17 1990-11-16 Pharmaceutical depot form,containing salmon calcitonin
CY1529A CY1529A (en) 1982-12-17 1990-11-16 Pharmaceutical depot form containing bromocriptine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH737282A CH660488A5 (en) 1982-12-17 1982-12-17 (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CH660488A5 true CH660488A5 (en) 1987-04-30

Family

ID=4324095

Family Applications (1)

Application Number Title Priority Date Filing Date
CH737282A CH660488A5 (en) 1982-12-17 1982-12-17 (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions

Country Status (3)

Country Link
JP (1) JPS59130252A (ja)
BE (1) BE898430A (ja)
CH (1) CH660488A5 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59139318A (ja) * 1983-01-31 1984-08-10 Mitsui Toatsu Chem Inc フイルム状またはシ−ト状の成形薬材の製造方法
JPH0725688B2 (ja) * 1986-03-31 1995-03-22 住友製薬株式会社 Ｃｓｆ徐放性製剤
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JP4317599B2 (ja) * 1996-06-26 2009-08-19 武田薬品工業株式会社 徐放性製剤
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
JP5622040B2 (ja) * 2010-09-14 2014-11-12 株式会社リコー トナー並びに現像剤、及びこれを用いた画像形成方法、トナー用熱可塑性樹脂
JP5696841B2 (ja) * 2011-03-10 2015-04-08 株式会社リコー トナー、二成分現像剤、画像形成方法、画像形成装置及びプロセスカートリッジ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
JPS592366B2 (ja) * 1978-09-27 1984-01-18 日本国有鉄道 超電導磁石
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
ATE37983T1 (de) * 1982-04-22 1988-11-15 Ici Plc Mittel mit verzoegerter freigabe.

Also Published As

Publication number Publication date
JPS59130252A (ja) 1984-07-26
BE898430A (fr) 1984-06-12

Similar Documents

Publication Publication Date Title
DE3345314A1 (de) Oligomere hydroxycarbonsaeurederivate, deren herstellung und verwendung
EP0274127B1 (de) Biologisch abbaubare Poly-(hydroxyalkyl)-Aminodicarbonsäure-Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben für Depotzubereitungen mit kontrollierter Wirkstoffabgabe
DE69302721T2 (de) Herstellungsverfahren für biologisch aktives Material enthaltende Polymere Mikrokapseln
DE69434418T2 (de) Orale Dareichungsform
DE69333817T2 (de) Leuprorelinpräparat mit verzögerter Wirkstoffabgabe
AT408609B (de) Zubereitung zur stetigen und kontrollierten abgabe von medikamentösen substanzen und verfahren zu deren herstellung
CH671402A5 (ja)
DE3430852C2 (de) Neue Ester, deren Herstellung und Verwendung
US5585460A (en) Biodegradable high-molecular polymers, production and use thereof
DE69121675T2 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
DE602006000381T2 (de) Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
JPS6254760A (ja) ポリオキシカルボン酸エステルおよびその製造法
DE2842088A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
EP0505966B1 (de) Langwirkende bioabbaubare Mikropartikel und ein Verfahren zur Herstellung
DE2842089A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
DE68924804T2 (de) Polypeptid mit sich wiederholenden zelladhäsiven Hauptsequenzen.
CH660488A5 (en) (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
EP0439846B1 (de) Biologisch abbaubare Polymere, Verfahren zu ihrer Herstellung und Verwendung derselben für Depotzubereitungen mit kontrollierter Wirkstoffabgabe
EP1152776B1 (de) Bioabbaubare, injizierbare oligomer-polymer-zusammensetzung
CH663718A5 (de) Pharmazeutische zusammensetzung enthaltend bromokryptin.
EP1002546A2 (de) Verwendung von Estern oder Amiden hydroxylierter Carbonsaüren als Solubilisatoren
CH666406A5 (de) Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
DE2748291C3 (de) Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen
CH651475A5 (en) Pharmaceutical composition for delayed release of the active substance under physiological conditions
NL8802490A (nl) Preparaat op basis van polyesters voor de gereguleerde afgifte van geneesmiddelen.

Legal Events

Date Code Title Description
PL Patent ceased